(Press-News.org) VIENNA, Austria, 1 October 2012 – New findings that highlight the challenges of managing thromboembolic events in patients being treated for cancer were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Venous thromboembolism causes symptoms in about 3 to 4% of cancer patients whose chemotherapy drugs are delivered via a central venous catheter, comments Dr. Fausto Roila, from Medical Oncology Department, Terni, Italy, Chair of the ESMO 2012 Supportive Care Track. "When asymptomatic patients are considered, these events affect about 12-18% of patients who have central venous catheters."
Efficacy of anticoagulation for cancer patients suggests guidelines should be reconsidered
Anticoagulants are effective for preventing deep vein thrombosis in cancer patients who have a central venous catheter in place for the delivery of chemotherapy, the results of a new French study reveal.
The risk of deep vein thrombosis (DVT) is higher among cancer patients than among the general population. Furthermore, patients undergoing chemotherapy often have central venous access devices implanted. These devices are associated with deep vein thrombosis, which can lead to a pulmonary embolism and in some cases, death. But whether an anticoagulant prophylaxis is needed for patients with cancer with a central venous catheter is a controversial subject.
Dr Sandrine Lavau-Denes, from Centre Hospitalier Universitaire à Limoges, and colleagues performed a phase III prospective, randomized trial in 407 patients and found that anticoagulation significantly reduced the incidence of catheter-related DVT.
"The current guidelines of the American Society of Clinical Oncology, American College of Chest Physicians, and the French National Federation of the League of Centers against Cancer do not recommend prophylactic anticoagulant treatment for cancer outpatients," Dr Lavau-Denes says. "In recent studies and meta-analyses, results are still contradictory, perhaps because of the heterogeneity of the screened patients. We think that these new results should lead to a new reflection."
Dr Fausto Roila, who was not involved in the study, said: "The incidence of CVC-related thrombosis was significantly lower with the two anticoagulant drugs [8.1% (22/272) versus 14.8% (20//135), respectively]." Dr. Roila noted however that the study has some limitations, among these the fact that it is a single-centre study requiring 11 years to be completed. Therefore, "the results of this study should be confirmed by other double-blind, randomized clinical trials, before changing the actual recommendations".
### Related studies presented at ESMO 2012
Real-world analysis shows risks and costs of venous thromboembolic events with chemotherapy
For patients with breast and prostate cancer, the risk of venous thromboembolism within the first months after initiation of chemotherapy is about 4% and almost doubles at 12 months, a new US analysis shows. The study used the US IMPACT claims database to retrospectively identify 34,144 patients with breast and prostate cancer.
Almost 20% of patients receiving cisplatin-based chemotherapy experience thromboembolic events
A retrospective analysis of 141 cancer patients treated with cisplatin-based chemotherapy finds that 19.1% experienced a thromboembolic event, including deep vein thrombosis, pulmonary embolism and arterial thrombosis. Patients with gastric and pancreatic cancers had the highest incidence of events. It is important to carry out randomized studies to conclude the need for prophylaxis of thromboembolic events in these patients, authors say.
New findings highlight the challenges of managing blood clotting in cancer patients
2012-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Should aspirin be used to prevent cancer?
2012-10-01
VIENNA, Austria, 1 October 2012 – Aspirin, the everyday drug taken by countless people around the world to ward off pain and reduce their risk of developing heart disease, may have a new trick up its sleeve –-preventing cancer.
A growing body of evidence suggests that taking aspirin may reduce an individual's chances of developing colorectal cancer and perhaps other malignancies, but whether that evidence is strong enough to outweigh the risks of prescribing it to millions of healthy people is the subject of debate.
At the ESMO 2012 Congress in Vienna, both sides of ...
Putting a 'HEX' on muscle regeneration
2012-10-01
A complex genetic regulatory network mediates the regeneration of adult skeletal muscles. In this issue of the Journal of Clinical Investigation, researchers at the State University of New York Downstate Medical Center in Brooklyn report that HEXIM1, a protein that regulates gene transcription, is important for skeletal muscle regeneration in mice. M.A.Q. Saddiqui and colleagues found that HEXIM1 blocks gene expression that is required for muscle regeneration after injury. Mice with a 50% reduction in HEXIM1 exhibited greater muscle mass and function after injury compared ...
JCI early table of contents for October 1, 2012
2012-10-01
Sphingolipid metabolism contributes to diabetes-associated heart disease
Patients with type 2 diabetes are subject to a number of major health risks, including a greatly increased risk of heart failure. This is due in part to the development of diabetic cardiomyopathy (DbCM), a condition that significantly impairs heart function. In this issue of the Journal of Clinical Investigation, Ashley Cowart and colleagues at the Medical University of South Carolina report that an increase in specific types of saturated fatty acids (SFAs) and fatty acid metabolic pathways cause ...
Public health messages can influence infectious disease stigmas
2012-10-01
UNIVERSITY PARK, Pa. -- Crafting public health messages about a disease may create stigmas that influence how likely people are to endorse certain interventions, such as isolating infected persons, forcing treatment on them and mapping their location, according to a Penn State researcher.
Rachel Smith, associate professor of communication arts and sciences and investigator with the University's Center for Infectious Disease Dynamics, used a hypothetical disease -- a virus carried by rodents -- to develop 16 different health alerts describing the virus and those who were ...
Preoperative needle breast biopsies can lead to improved treatment outcomes
2012-10-01
Chicago: Women suspected of having breast cancer now have more reasons to be diagnosed with a needle biopsy instead of a traditional open surgical biopsy. Besides avoiding the risks and discomfort of an open surgical procedure, needle biopsies can also lead to improved treatment outcomes according to findings from a new study published in the October issue of the Journal of the American College of Surgeons.
Breast cancer is the number one form of cancer diagnosed in women in the United States, according to the U.S. Centers for Disease Control and Prevention. [1] In ...
Researchers identify a Dance Dance Revolution in kids' physical activity
2012-10-01
A study published in Pediatrics this morning by researchers at the University of Montreal offers positive news for Wii-loving teenagers and their parents: games such as Wii Sports and Dance Dance Revolution can bring them closer to recommended physical activity levels. The study is the first of its kind. "Teenage exergamers – people who play video games that require physical activity – are most likely females who are stressed about their weight. On average, they play two 50 minute sessions per week," said study author Jennifer O'Loughlin of the university's Department of ...
Nano-hillocks: Of mountains and craters
2012-10-01
In the field of nanotechnology, electrically-charged particles are frequently used as tools for surface modification. Researchers at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) and the TU Vienna were at last able to reconcile important issues concerning the effects of highly charged ions on surfaces.
Ion beams have been used for some time now for surface modification as ions are capable of carrying such high energies that a single particle alone can induce drastic changes to the surface under bombardment. Following careful examination, an international team of researchers ...
Study reveals how memory load leaves us 'blind' to new visual information
2012-10-01
Trying to keep an image we've just seen in memory can leave us blind to things we are 'looking' at, according to the results of a new study supported by the Wellcome Trust.
It's been known for some time that when our brains are focused on a task, we can fail to see other things that are in plain sight. This phenomenon, known as 'inattentional blindness', is exemplified by the famous 'invisible gorilla' experiment in which people watching a video of players passing around a basketball and counting the number of passes fail to observe a man in a gorilla suit walking across ...
Physiological role of a novel hormone FNDC5/irisin revealed in humans
2012-10-01
Oxford, October 1, 2012 - A research team led by Dr. Christos Mantzoros, MD, PhD, at Beth Israel Deaconess Medical Center, Harvard Medical School, has published new findings elucidating the molecular and clinical role of FNDC5/irisin in humans.
Irisin is a recently identified hormone secreted from muscle cells that has been found to serve as a chemical messenger providing key exercise-induced health benefits in mice. In these earlier studies, irisin showed direct effects on 'browning' of white fat which would lead to burning of excess calories. Discovery of irisin therefore ...
Computerized osteoporosis detection
2012-10-01
A computerized approach to examining patient bone X-rays for diagnosis of osteoporosis could side-step the subjectivity associated with visual examination, according to a new research paper in the International Journal of Biomedical Engineering and Technology published in October.
Neelesh Kumar of the Central Scientific Instruments Organisation in Chandigarh, India, and colleagues recognized that the bone disorder osteoporosis is on the increase but that diagnosis using X-ray images of the patient's skeleton often lead to false positives and false negatives because visual ...